Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins.
PAF-acether (PAF) is a newly formed mediator not normally present in circulating blood. A compound exhibiting all of its biological characteristics but coeluting with phosphatidylcholine (PC) in high-pressure liquid chromatography (HPLC) was unveiled ('peak X') in normal human plasma. A second HPLC run of peak X HPLC fractions revealed the presence of PAF itself with concomitant disappearance of peak X. Beside PAF, immunoreactive apolipoproteins A-I and E were found in peak X. Also lipoproteins (Ls) purified using either ultracentrifugation or immunoaffinity chromatography yielded peak X and, in a second HPLC run, authentic PAF. L-free plasma was devoid of peak X. Finally, after preincubation with plasma, labeled PAF was found associated with Ls. Thus in human blood preformed PAF is bound in high amounts to Ls, a result of interest given the role of Ls and platelets in vascular diseases and the present knowledge on PAF biosynthesis.
Benveniste
J
J
INSERM U 200, Université Paris-Sud, Clamart, France.
Nunez
D
D
Duriez
P
P
Korth
R
R
Bidault
J
J
Fruchart
J C
JC
D002846:Chromatography, Affinity; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000302:isolation & purification; D010972:Platelet Activating Factor / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism*; D011485:Protein Binding; D014316:Tritium
D008074:Lipoproteins; C029271:O-deacetyl platelet activating factor; D010972:Platelet Activating Factor; D014316:Tritium